No Data
No Data
IDreamSky Technology Launches Share Buyback Plan
IDREAMSKY's buyback boosted its stock price performance, with an intraday increase of over 14%.
① How does the Board of Directors of IDREAMSKY view the current stock price? ② How is the company's recent situation?
Selected announcements from Gelonghui (Hong Kong stocks) | WUXI BIO (02269.HK) intends to sell assets related to the Irish vaccine facility for 0.5 billion US dollars.
【Today's Focus】WUXI BIO (02269.HK) plans to sell assets related to the Ireland vaccine facility for 0.5 billion USD. WUXI BIO (02269.HK) announced that on January 6, 2025, the company and WUXI HAI DE Ireland (the seller, a wholly-owned subsidiary of the company) entered into an agreement with MSD International (the buyer), according to which, subject to the terms and conditions of the agreement, the seller has conditionally agreed to sell and the buyer has conditionally agreed to purchase assets related to the Ireland vaccine facility, with a total consideration of approximately 500 million USD. The Ireland vaccine facility produces commercial products for the buyer.
IDREAMSKY (01119.HK) stock price fluctuations, plans to repurchase no more than 0.2 billion Hong Kong dollars of company shares.
Gelonghui January 6丨IDREAMSKY (01119.HK) announced that the Board of Directors has noted the recent fluctuations in the company's share price and trading volume.
IDREAMSKY (01119) plans to repurchase shares not exceeding 0.2 billion Hong Kong dollars.
IDREAMSKY (01119) announced that the Board of Directors has noted the recent fluctuations in the company's share price and trading volume. The company hereby informs...
On January 6, IDREAMSKY (01119.HK) spent 3.4099 million Hong Kong dollars to repurchase 1.9828 million shares.
Gelonghui announced on January 6 that IDREAMSKY (01119.HK) spent HKD 3.4099 million to repurchase 1.9828 million shares, with a repurchase price of HKD 1.7-1.78 per share.